We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $783M
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P
Everpure Inc
P
+$3.43M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGEN
151
Agenus
AGEN
$326M
$1.28M 0.16%
+418,581
New +$1.5M
SGHC icon
152
SGHC Ltd
SGHC
$6.5B
$1.27M 0.16%
93,358
+850
+0.9% +$10.8K
INDV icon
153
Indivior Pharmaceuticals
INDV
$4.21B
$1.24M 0.16%
30,280
KOP icon
154
Koppers
KOP
$873M
$1.22M 0.16%
27,190
ORN icon
155
Orion Group Holdings
ORN
$366M
$1.2M 0.15%
71,310
AXS icon
156
AXIS Capital
AXS
$7.3B
$1.2M 0.15%
11,158
-262
-2% -$26.3K
SRI icon
157
Stoneridge
SRI
$205M
$1.2M 0.15%
163,443
-45,406
-22% -$312K
TCBX icon
158
Third Coast Bancshares
TCBX
$739M
$1.19M 0.15%
29,564
-2,297
-7% -$89.5K
EVER icon
159
EverQuote
EVER
$807M
$1.19M 0.15%
49,969
QCOM icon
160
Qualcomm
QCOM
$202B
$1.18M 0.15%
6,405
XERS icon
161
Xeris Biopharma Holdings
XERS
$1.49B
$1.16M 0.15%
145,917
+22,733
+18% +$145K
HWM icon
162
Howmet Aerospace
HWM
$90B
$1.15M 0.15%
4,292
MLAB icon
163
Mesa Laboratories
MLAB
$711M
$1.15M 0.15%
11,581
+743
+7% +$74.8K
VTEX icon
164
VTEX
VTEX
$603M
$1.14M 0.15%
285,953
FMBH icon
165
First Mid Bancshares
FMBH
$1.33B
$1.14M 0.15%
23,714
EHC icon
166
Encompass Health
EHC
$12.1B
$1.12M 0.14%
11,065
KINS icon
167
Kingstone Companies
KINS
$289M
$1.11M 0.14%
58,102
-116
-0.2% -$1.87K
FLXS icon
168
Flexsteel Industries
FLXS
$325M
$1.1M 0.14%
14,806
IRWD icon
169
Ironwood Pharmaceuticals
IRWD
$699M
$1.09M 0.14%
259,809
NXDR
170
Nextdoor Holdings
NXDR
$959M
$1.09M 0.14%
481,684
+387,108
+409% +$723K
VRT icon
171
Vertiv
VRT
$93B
$1.08M 0.14%
3,235
-1,165
-26% -$369K
GSBC icon
172
Great Southern Bancorp
GSBC
$865M
$1.08M 0.14%
13,796
KEYS icon
173
Keysight
KEYS
$56.4B
$1.07M 0.14%
3,066
ESOA icon
174
Energy Services of America
ESOA
$203M
$1.06M 0.14%
+54,775
New +$893K
LQDT icon
175
Liquidity Services
LQDT
$1.35B
$1.06M 0.14%
27,002

Similar funds

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.